Analyst Ratings for Moderna (MRNA) [Buys]
MRNA Rating Summary
MRNA Price Target Summary
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$133.60 (+25.8%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 42%
Avg. $ Target:
$133.60 (+25.8%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 42%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/2/2024 | Oppenheimer | Hartaj Singh | Upgrade | Outperform (Perform) |
142.00 (N/A) |
99.45 (106.18) |
6.77% | Details |
| 6/26/2023 | UBS » Updated 3/27/2024 |
Eliana Merle | Upgrade | Buy (Neutral) |
143.00 (N/A) |
120.48 (106.18) |
-11.87% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
